Groupe Athena, Inc. Issues Update on Atorvastatin Calcium Project
ACCESSWIRE - Thu Feb 19, 7:16AM CST
MUMBAI, IN / ACCESSWIRE / February 19, 2015 / Groupe Athena, Inc. (OTC: GATA) (PINKSHEETS: GATA) announced today that the company has started Pharmacokinetic (PK) modeling as part of its preclinical studies in its continuing efforts to start production of Atorvastatin Calcium. Pharmacokinetic modeling is a mathematical technique for predicting the effect and efficacy of drug dosing over time. Broadly speaking, pharmacokinetic models describe how the body reacts to a drug in terms of absorption, distribution, metabolism, and excretion.
Groupe Athena, Inc. Announces Revenue Update
ACCESSWIRE - Tue Feb 17, 7:16AM CST
MUMBAI, IN / ACCESSWIRE / February 17, 2015 / Groupe Athena, Inc. (OTC: GATA) (PINKSHEETS: GATA), announced on September 23, 2013 that based on the orders in hand, the company expects to achieve total revenues of $70 million in the current fiscal. The company is on track to report revenue of $16.5 million for the current quarter, which would reflect a growth 14% over the corresponding quarter of the previous year.
Groupe Athena, Inc. Posts 2nd Quarter Results
ACCESSWIRE - Wed Jan 21, 8:57AM CST
MUMBAI, INDIA / ACCESSWIRE / January 21, 2015 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $19,005,429 for the period ending December 31, 2014, an increase of $1,043,977 over the same period in 2013. Operating income before Depreciation and Amortization was $2,845,789 and reflects a Research and Development charge of $428,659. Net income for the period was $1,859,924 or $.04 per share.
Groupe Athena, Inc. Posts Strong 1st Quarter Results, Sees Progress Toward Transition To Manufacturing
ACCESSWIRE - Mon Nov 17, 8:16AM CST
Mumbai, India / ACCESSWIRE / November 17, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $20,181,962 for the period ending September 30, 2014, which represents an increase of $1,419,373 over the same period in 2013. Gross income before depreciation, amortization and taxes was $1,423,850. Operating income before Depreciation and Amortization was $1,423,850 and reflects a Research and Development charge of $1,862,065.
Groupe Athena, Inc. Issues Revenue Guidance
ACCESSWIRE - Tue Sep 02, 8:19AM CDT
MUMBAI, INDIA / ACCESSWIRE / September 2, 2014 / Groupe Athena, Inc. (OTC PINK: GATA), (PINKSHEETS: GATA), announced today that based on current orders in hand they anticipate a strong first quarter and project total revenue for the period could top $20 million for the first time.
Groupe Athena, Inc. Posts Year End Financials, Betters Previous Record by 15%, Marks 5th Consecutive Double Digit Gain in Annual Revenue
ACCESSWIRE - Mon Jul 28, 3:24PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 28, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) has posted the results for their fiscal year ending June 30, 2014. Annual revenue for the period was $65,189,762 which is an increase of more than 15% over the previous record fiscal year and represents an amazing 5th consecutive double digit increase in annual revenue. EBITDA for the year was also a record $10,938,698 and net after tax income for the period was $6,501,645 or $.14 per share.
Groupe Athena, Inc Sets Release Date for Year End Financials Release, Reiterates Revenue Guidance
ACCESSWIRE - Mon Jul 21, 3:20PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 21, 2014 / Groupe Athena, Inc. (OTC: Pink sheets GATA) announced today they will release their financial results for the fiscal year ended June 30, 2014 after the close of the market on July 28.